MedTrace Logo

Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease

NCT02726243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2024-02-28

No results posted yet for this study

Summary

Build a collection of fecal microbiota in order to determine the characteristics of gut microbiota associated with colorectal cancer in Inflammatory bowel disease (IBD).

Conditions

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Harry SOKOL, MD PhD · APHP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02726243 on ClinicalTrials.gov